SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-21-001001
Filing Date
2021-01-12
Accepted
2021-01-12 16:24:01
Documents
13
Period of Report
2021-01-09
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K dvax-8k_20210109.htm   iXBRL 8-K 34125
2 EX-10.1 dvax-ex101_6.htm EX-10.1 335299
  Complete submission text file 0001564590-21-001001.txt   556256

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA dvax-20210109.xsd EX-101.SCH 5772
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE dvax-20210109_lab.xml EX-101.LAB 19478
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE dvax-20210109_pre.xml EX-101.PRE 11627
6 EXTRACTED XBRL INSTANCE DOCUMENT dvax-8k_20210109_htm.xml XML 3558
Mailing Address 2100 POWELL STREET SUITE 900 EMERYVILLE CA 94608
Business Address 2100 POWELL STREET SUITE 900 EMERYVILLE CA 94608 5108485100
DYNAVAX TECHNOLOGIES CORP (Filer) CIK: 0001029142 (see all company filings)

IRS No.: 330728374 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34207 | Film No.: 21523768
SIC: 2834 Pharmaceutical Preparations